Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Age-related decrease in transplantability of human tumours in nu/nu mice.

J Bubeník1, J Kieler, T Jandlová

  • 1Institute of Molecular Genetics, Czechoslovak Academy of Sciences, Flemingovo.

Anticancer Research
|September 1, 1992
PubMed
Summary

As mice age, their ability to grow human tumor xenografts declines, linked to increased interleukin-2 (IL-2) production. Supplementing young mice with IL-2 inhibited tumor growth, suggesting a role for IL-2 in tumor transplantability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reporting framework in the testing of predisposition to common adult solid tumors using next-generation sequencing.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

[Malignant Melanoma - from Classical Histology towards Molecular Genetic Testing].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2017
Same author

NOD2/CARD15 mutations and the risk of reoperation in patients with Crohns disease.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2015
Same author

Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells.

Cell death and differentiation·2014
Same author

Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction.

Folia biologica·2013
Same author

Serum levels of matrix metalloproteinases 2 and 9 and TGFBR2 gene screening in patients with ascending aortic dilatation.

Folia biologica·2013

Area of Science:

  • Immunology
  • Oncology
  • Aging Research

Background:

  • Age-related changes in immune function can impact cancer progression and treatment outcomes.
  • Congenitally athymic (nu/nu) mice are commonly used models for human tumor xenografts.
  • Interleukin-2 (IL-2) is a critical cytokine for T-cell proliferation and function.

Purpose of the Study:

  • To investigate the effect of recipient age on the transplantability of human tumors in nu/nu mice.
  • To determine if exogenous interleukin-2 (IL-2) administration influences human tumor xenograft growth in young nu/nu mice.
  • To explore the relationship between IL-2 production, effector cell maturation, and age-related changes in tumor transplantability.

Main Methods:

  • Xenotransplantation of human tumors into BALB/c nu/nu mice of varying ages.

Related Experiment Videos

  • Administration of exogenous IL-2 to young adult nu/nu mice.
  • In vitro activation of nu/nu splenocytes with IL-2 and assessment of killer cell activity.
  • Flow cytometry analysis of IL-2-activated Thy 1.2+ and ASGM1+ cell populations.

    • Main Results:

    • A significant decrease in progressively growing human tumor xenografts was observed with increasing age of nu/nu recipients.
    • Peritumoral administration of exogenous IL-2 to young nu/nu mice inhibited human tumor xenograft growth.
    • In vitro, IL-2 activated splenocytes generated cytotoxic killer cells against human tumor targets.
    • The percentage of IL-2-activated Thy 1.2+ and ASGM1+ cells increased with the age of nu/nu spleen cell donors.

    Conclusions:

    • Age-related decline in human tumor xenograft take in nu/nu mice correlates with increased endogenous IL-2 production.
    • Exogenous IL-2 administration can inhibit tumor xenograft growth, highlighting IL-2's role in transplantability.
    • Increased IL-2 levels with age may lead to enhanced maturation of IL-2-dependent effector cells, contributing to reduced tumor take.